Differential activations of PKC/PKA related to microvasculopathy in diabetic GK rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 2, 2012, Pages

  Wang, Hui ^a,b   Jiang, Yong Wei ^a,b   Zhang, Wen Jian ^b   Xu, Shi Qing ^b   Liu, Hong Lin ^b   Yang, Wen Ying ^b   Lou, Jin Ning ^b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Advanced glycation end products; Diabetic microvasculopathy; Diabetic nephropathy; Goto Kakizaki rat; Protein kinase A; Protein kinase C

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN KINASE C; PROTEIN KINASE C BETA; REACTIVE OXYGEN METABOLITE; RUBOXISTAURIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ASSAY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ALBUMINURIA; ANIMALS; BRAIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; KIDNEY FAILURE, CHRONIC; LIVER; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASE C; RATS;

EID: 84855307239     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00184.2011     Document Type: Article

References (62)

1. Adeghate E, Ponery AS, Sheen R. Streptozotocin-induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenaline and adrenaline in the rat. Pancreas 22: 311-316, 2001.
2. Avignon A, Sultan A. PKC-B inhibition: a new therapeutic approach for diabetic complications? Diabetes Metab 32: 205-13, 2006.
3. Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S; ONTARGET, Investigators TRANSCEND. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med 171: 142-150, 2011.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
6. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, Trimble ER. The effect of endothelin 1 on the retinal microvascular pericyte. Microvasc Res 43: 241-254, 1992.
7. Chan O, Chan S, Inouye K, Shum K, Matthews SG, Vranic M. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 51: 1681-1689, 2002.
8. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, Hsia CC. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31: 1596-1601, 2008.
9. Chen G, Brunt EM. Diabetic hepatosclerosis: a 10-year autopsy series. Liver Int 29: 1044-1050, 2009.
10. Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, Chisolm GM, Almasan A. The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 10: 323-334, 2003.
11. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55: 498-510, 2007.
12. Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 113: 546-593, 2007.
13. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77: S3-S12, 2000.
14. Ejaz S, Chekarova I, Ejaz A, Sohail A, Lim CW. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 10: 53-63, 2008.
15. Ferreira F, Barbosa HC, Stoppiglia LF, Delghingaro-Augusto V, Pereira EA, Boschero AC, Carneiro EM. Decreased insulin secretion in islets from rats fed a low protein diet is associated with a reduced PKA alpha expression. J Nutr 134: 63-67, 2004.
16. Fu Z, Zhang W, Zhen W, Lum H, Nadler J, Bassaganya-Riera J, Jia Z, Wang Y, Misra H, Liu D. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151: 3026-3037, 2010.
17. Grammas P, Moore P, Cashman RE, Floyd RA. Anoxic injury of endothelial cells causes divergent changes in protein kinase C and protein kinase A signaling pathways. Mol Chem Neuropathol 33: 113-124, 1998.
18. Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch Pathol Lab Med 130: 27-32, 2006.
19. Hudacko RM, Sciancalepore JP, Fyfe BS. Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications. Am J Clin Pathol 132: 494-499, 2009.
20. Idris I, Gray S, Donnelly R. Protein kinase C activation: isozymespecific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44: 659-673, 2001.
21. Irie K, Fujii E, Ishida H, Wada K, Suganuma T, Nishikori T, Yoshioka T, Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide induced microvascular permeability change in mouse skin. Brit J Pharmacol 133: 237-242, 2001.
22. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272: 728-731, 1996.
23. Kanda T, Ariga T, Yamawaki M, Yu RK. GM3 regulates protein kinase systems in cultured brain microvascular endothelial cells. J Neurochem 61: 1969-1972, 1993.
24. Kern TS, Engerman RL. Capillary lesion develop in retina rather than in cerebral cortex in diabetes and experimental galactosemia. Arch Ophthalmol 114: 306-310, 1996.
25. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52: 2603-2614, 2003.
26. Koike N, Takamura T, Kaneko S. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor. Life Sci 80: 1721-1728, 2007.
27. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284: F1121-F1137, 2003.
28. Kouroedov A, Eto M, Joch H, Volpe M, Lüscher TF, Cosentino F. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 110: 91-96, 2004.
29. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo:a specific vascular action of insulin. Circulation 101: 676-681, 2000.
30. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complication. Proc Natl Acad Sci USA 86: 5141-5145, 1989.
31. Levy FO, Ree AH, Eikvar L, Govindan MV, Jahnsen T, Hansson V. Glucocorticoid receptors and glucocorticoid effects in rat Sertoli cells. Endocrinology 124: 430-436, 1989.
32. Lou J, Gasche Y, Zheng L, Critico B, Monso-Hinard C, Juillard P, Morel P, Buurman WA, Grau GE. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria. Eur J Immunol 28: 3989-4000, 1998.
33. Matsumoto T, Wakabayashi K, Kobayashi T, Kamata K. Diabetesrelated changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery. Am J Physiol Heart Circ Physiol 287: H1064-H1071, 2004.
34. Menne J, Meier M, Park JK, Haller H. Inhibition of protein kinase C in diabetic nephropathy-where do we stand? Nephrol Dial Transplant 24: 2021-2023, 2009.
35. Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22: 8467-8477, 2002.
36. Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, Jacobs JR, Clermont AC, Ueki K, Ohshiro Y, Zhang J, Goldfine AB, King GL. Activation of vascular protein kinase C-beta inhibits Aktdependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55: 691-698, 2006.
37. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three different pathways of hyperglycemic damage. Nature 404: 787-790, 2000.
38. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH. Glucagon-like peptide 1 prevents reactive oxygen speciesinduced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 30: 1407-1414, 2010.
39. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN, Pratt LM, Russo LM, Kemp BE, Comper WD, Jerums G. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin- induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 49: 87-93, 2000.
40. Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ. Adiponectin suppression of highglucose- induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55: 1840-1846, 2006.
41. Oyen O, Sandberg M, Eskild W, Levy FO, Knutsen G, Beebe S, Hansson V, Jahnsen T. Differential regulation of messenger ribonucleic acids for specific subunits of cyclic adenosine 3=,5=-monophosphate (cAMP)-dependent protein kinase by cAMP in rat sertoli cells. Endocrinology 122: 2658-2666, 1988.
42. Pérez LM, Milkiewicz P, Elias E, Coleman R, Sánchez Pozzi EJ, Roma MG. Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A. Toxicol Sci 91: 150-158, 2006.
43. Pérez LM, Milkiewicz P, Ahmed-Choudhury J, Elias E, Ochoa JE, Sánchez Pozzi EJ, Coleman R, Roma MG. Oxidative stress induces actin-cytoskeletal and tight-junctional alterations in hepatocytes by a Ca2-dependent, PKC-mediated mechanism: protective effect of PKA. Free Radic Biol Med 40: 2005-2017, 2006.
44. Rask-Madsen C, King GL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 25: 487-496, 2005.
45. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Iiaw CW, Manning K, Morales J. A cell culture model of the blood-brain barrier. J Cell Biol 115: 1725-1735, 1991.
46. Scheurich P, Köbrich G, Pfizenmaier K. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C. J Exp Med 170: 947-958, 1989.
47. Shah DI, Singh M. Activation of protein kinase A improves vascular endothelial dysfunction. Endothelium 13: 267-277, 2006.
48. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol and protein kinase C in rat retina to retinal circulation. Am J Physiol Endocrinol Metab 265: E783-E793, 1993.
49. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57: 460-469, 2008.
50. Toba H, Gomyo E, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Asayama J, Kobara M, Nakata T. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta. Clin Exp Pharmacol P 33: 440-447, 2006.
51. Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28: 2686-2690, 2005.
52. Tuttle KR, Anderberg RJ, Cooney SK, Meek RL. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet. Am J Nephrol 29: 171-180, 2008.
53. Umegaki H. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing 39: 8-10, 2010.
54. Unglaub R, Maxeiner B, Thoma B, Pfizenmaier K, Scheurich P. Down regulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase c activators. J Exp Med 166: 1788-1797, 1987.
55. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 18: 945-59, 2001.
56. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996.
57. Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose- 6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 289: F1040-F1047, 2005.
58. Yamakawa H, Jezova M, Ando H, Saavedra JM. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23: 371-380, 2003.
59. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4: 285-293, 2008.
60. Yang S, Fransson U, Fagerhus L, Holst LS, Hohmeier HE, Renstrom E, Mulder H. Enhanced cAMP protein kinase A signaling determines improved insulin secretion in a clonal insulin-producing beta-cell line (INS-1 832/13). Mol Endocrinol 18: 2312-2320, 2004.
61. Yokota T, Ma RC, Park JY, Isshiki K, Sotiropoulos KB, Rauniyar RK, Bornfeldt KE, King GL. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 52: 829-837, 2003.
62. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 39: 213-23, 2002.